Cardinale Smith and Ash Tewari to lead Tisch Cancer Hospital at the Mount Sinai Hospital

RAS-mutant leukemia stem cells behave differently from other leukemia stem cells

Research from the Icahn School of Medicine at Mount Sinai provides new insights into acute myeloid leukemia and its resistance to a common treatment. The study, published Oct. 30 in Nature, was led by Eirini Papapetrou, professor of oncological sciences at Icahn Mount Sinai. Acute myeloid leukemia is a devastating blood cancer that starts in...

November 08, 2024

Vol.50 No.42

In Brief

Mount Sinai launches Center of Excellence for patients with gynecologic cancer

Mount Sinai Health System has launched its Center of Excellence for Gynecologic Cancer, which is part of The Tisch Cancer Institute. This new Center of Excellence offers a comprehensive range of services, including advanced gynecologic cancer screening and diagnosis, innovative treatments, and access to supportive care.

September 20, 2024

Vol.50 No.35

In Brief

Miriam Merad named dean for Translational Research and Therapeutic Innovation at Mt. Sinai

Miriam Merad was named dean for Translational Research and Therapeutic Innovation of the Icahn School of Medicine at Mount Sinai.

May 03, 2024

Vol.50 No.18

In Brief

Icahn School of Medicine at Mount Sinai receives $5M NCI grant for NIH Cancer Target Discovery and Development Center

The Department of Immunology and Immunotherapy and the Icahn Genomics Institute at the Icahn School of Medicine at Mount Sinai has received a $5 million grant from NCI to establish a center dedicated to the discovery and development of cutting-edge targets for cancer therapy.

November 17, 2023

Vol.49 No.43

Clinical Roundup

Mount Sinai researchers find more than 4,700 gene clusters crucial for prognosis in 32 cancer types

Researchers at the Mount Sinai Center for Transformative Disease Modeling have released a groundbreaking study identifying 4,749 key gene clusters, termed “prognostic modules,” that significantly influence the progression of 32 different types of cancer.

November 17, 2023

Vol.49 No.43

Clinical Roundup

PFAS forever chemicals could be a risk factor in thyroid cancer, Mount Sinai researchers find

Mount Sinai researchers have discovered a link between certain per- and polyfluoroalkyl substances and an increased risk for thyroid cancer, according to a study published in eBioMedicine.

October 27, 2023

Vol.49 No.40

Cardinale Smith and Ash Tewari to lead Tisch Cancer Hospital at the Mount Sinai Hospital

YOU MAY BE INTERESTED IN

RAS-mutant leukemia stem cells behave differently from other leukemia stem cells

Mount Sinai launches Center of Excellence for patients with gynecologic cancer

Miriam Merad named dean for Translational Research and Therapeutic Innovation at Mt. Sinai

Icahn School of Medicine at Mount Sinai receives $5M NCI grant for NIH Cancer Target Discovery and Development Center

Mount Sinai researchers find more than 4,700 gene clusters crucial for prognosis in 32 cancer types

PFAS forever chemicals could be a risk factor in thyroid cancer, Mount Sinai researchers find

Renew today!

Subscriber content

Never miss an issue!

Login